GlassScriptPhysician profile
Sharon Stewart
NPI 1124046214
$1,653.79
in general payments reported to CMS, 2019-2025
30 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $54.92 · 2021: $249 · 2022: $262 · 2023: $282 · 2024: $287 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $315.48 | 2019-2025 | |
| Hologic Sales and Service, LLC | $149.31 | 2019-2025 | Thinprep 2000 Processor, Aptima, Affirm Prone Biopsy System |
| Mayne Pharma Commercial LLC | $128.45 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $126.14 | 2019-2024 | |
| Organon LLC | $92.54 | 2022-2025 | Jada System |
| Coopersurgical, INC. | $88.98 | 2021-2025 | Advincula Delineator Uterine Manipulator, Paragard T 380a, Mara Console |
| Sage Therapeutics, LLC | $73.76 | 2021-2025 | Zurzuvae |
| Myovant Sciences INC. | $57.70 | 2021-2022 | |
| Astellas Pharma US INC | $56.14 | 2023-2024 | Veozah |
| Evofem Biosciences, INC. | $53.92 | 2021-2022 | |
| Baxter Healthcare | $48.57 | 2019-2023 | Tisseel |
| Pfizer INC. | $43.74 | 2023-2024 | |
| Shield Therapeutics INC | $41.88 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $40.28 | 2023-2024 | Myfembree |
| Duchesnay USA Incorporated | $35.98 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $32.44 | 2024-2025 | |
| Ethicon US, LLC | $31.29 | 2019 | |
| Mylan Pharmaceuticals INC. | $30.77 | 2021 | |
| Covidien LP | $24.21 | 2019 | |
| Conmed Corporation | $24.08 | 2024 | Airseal |
| Abbott Laboratories | $22.70 | 2022 | |
| Vertical Pharmaceuticals, LLC | $20.08 | 2019 | |
| Roche Diagnostics Corporation | $19.19 | 2019 | |
| Asensus Surgical, INC. | $16.53 | 2022 | |
| Channel Medsystems, INC. | $16.45 | 2023 | |
| Exeltis, USA INC. | $14.37 | 2021 | |
| Therapeuticsmd, INC. | $14.00 | 2021 | |
| Amag Pharmaceuticals, INC. | $12.06 | 2019 | |
| Lupin INC. | $11.75 | 2019 | |
| Avion Pharmaceuticals | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.